<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-21718" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Fever of Unknown Origin</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Brown</surname>
            <given-names>Ilona</given-names>
          </name>
          <aff>Cape Fear Valley Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Finnigan</surname>
            <given-names>Nancy A.</given-names>
          </name>
          <aff>Campbell University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ilona Brown declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Nancy Finnigan declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>14</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-21718.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Fever of unknown origin (FUO) was first described by Dr. Petersdorf and Dr. Beesom in 1961. FUO was defined as a temperature of 101 degrees Fahrenheit (38.3 degrees Centigrade) or higher with a minimum duration of three weeks without an established diagnosis after an intensive one-week investigation in the hospital. Today, due to technological advances allowing for sophisticated outpatient evaluations, the one-week inpatient investigation is no longer required. This activity reviews the cause and presentation of fever of unknown origin and highlights the role of the interprofessional team in its management.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the workup of a patient with a fever of unknown origin.</p></list-item><list-item><p>Outline the causes for fever of unknown origin.</p></list-item><list-item><p>Summarize the treatment of patients with fever of unknown origin.</p></list-item><list-item><p>Review the importance of improving care coordination among interprofessional team members to improve outcomes for patients affected by fever of unknown origin.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21718&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21718">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-21718.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Fever of unknown origin (FUO) was first described by Dr. Petersdorf and Dr. Beesom in 1961.<xref ref-type="bibr" rid="article-21718.r1">[1]</xref>&#x000a0;FUO was defined as a temperature of 101 degrees Fahrenheit (38.3 degrees Centigrade) or higher with a minimum duration of three weeks without an established diagnosis&#x000a0;despite at least one week's investigation in the hospital. This definition was later changed to accommodate technological advances allowing for sophisticated outpatient evaluations, increasing numbers of immunocompromised individuals including those with human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS), and more complex treatment options becoming available. The revised definition proposed by Durack and Street in 1991 divided cases into four distinct subclasses: classic FUO, nosocomial FUO, neutropenic FUO, and HIV-related FUO.<xref ref-type="bibr" rid="article-21718.r2">[2]</xref></p>
        <p>A&#x000a0;comprehensive history&#x000a0;and physical examination can aid in diagnosis and direct diagnostic testing. Recommended investigations for work-up include complete blood count (CBC) with differential, three sets of blood cultures (from different sites, several hours apart, and before initiation of antibiotic therapy, if&#x000a0;indicated), chest radiograph, complete metabolic panel (including hepatitis serologies if liver function tests are abnormal), urinalysis with microscopy and urine culture, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), antinuclear antibodies (ANA), rheumatoid factor (RA), cytomegalovirus IgM antibodies or virus detection in blood, heterophile antibody test, tuberculin skin test, HIV&#x000a0;testing and computed tomography (CT) scan of the abdomen.<xref ref-type="bibr" rid="article-21718.r3">[3]</xref></p>
        <p>Over 200 malignant/neoplastic, infectious, rheumatic/inflammatory, and miscellaneous disorders can cause FUO.<xref ref-type="bibr" rid="article-21718.r4">[4]</xref>&#x000a0;Providers often order non-clue-based imaging and specific testing early in the FUO workup, which may be misleading and is certainly not economical.<xref ref-type="bibr" rid="article-21718.r4">[4]</xref>&#x000a0;Despite extensive workup and diagnostic advances, up to 51% of FUO cases remain undiagnosed.<xref ref-type="bibr" rid="article-21718.r5">[5]</xref><xref ref-type="bibr" rid="article-21718.r6">[6]</xref>&#x000a0;In modern medicine, FUO remains one of the most challenging diagnoses.</p>
        <p>It is important to note that immunocompromised and HIV patients may require an entirely&#x000a0;different approach in diagnosing and treatment of recurrent fevers. This article focuses on FUO in immunocompetent adult patients.<xref ref-type="bibr" rid="article-21718.r3">[3]</xref></p>
      </sec>
      <sec id="article-21718.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The causes of fever of unknown origin (FUO) are often common conditions presenting atypically. The list of causes is extensive, and it is broken down into broader categories, such as infection, noninfectious inflammatory conditions, malignancies, and miscellaneous.</p>
        <p>
<bold>Noninfectious Inflammatory Causes of FUO</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Giant cell (temporal) arteritis</p>
          </list-item>
          <list-item>
            <p>Adult Still disease (juvenile rheumatoid arthritis)</p>
          </list-item>
          <list-item>
            <p>Systemic lupus erythematosus (SLE)</p>
          </list-item>
          <list-item>
            <p>Periarteritis nodosa/microscopic polyangiitis (PAN/MPA)</p>
          </list-item>
          <list-item>
            <p>Rheumatoid arthritis (RA)</p>
          </list-item>
          <list-item>
            <p>Antiphospholipid syndrome (APS)</p>
          </list-item>
          <list-item>
            <p>Gout</p>
          </list-item>
          <list-item>
            <p>Pseudogout</p>
          </list-item>
          <list-item>
            <p>Beh&#x000e7;et disease</p>
          </list-item>
          <list-item>
            <p>Sarcoidosis</p>
          </list-item>
          <list-item>
            <p>Felty syndrome</p>
          </list-item>
          <list-item>
            <p>Takayasu arteritis</p>
          </list-item>
          <list-item>
            <p>Kikuchi disease</p>
          </list-item>
          <list-item>
            <p>Periodic fever adenitis pharyngitis aphthous ulcer (PFAPA) syndrome</p>
          </list-item>
        </list>
        <p>
<bold>Infectious Causes of FUO</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Tuberculosis (TB)</p>
          </list-item>
          <list-item>
            <p>Q fever</p>
          </list-item>
          <list-item>
            <p>Brucellosis</p>
          </list-item>
          <list-item>
            <p>HIV infection</p>
          </list-item>
          <list-item>
            <p>Abdominopelvic abscesses</p>
          </list-item>
          <list-item>
            <p>Cat scratch disease (CSD)</p>
          </list-item>
          <list-item>
            <p>Epstein-Barr virus (EBV) infection</p>
          </list-item>
          <list-item>
            <p>Cytomegalovirus (CMV) infection</p>
          </list-item>
          <list-item>
            <p>Enteric (typhoid) fever</p>
          </list-item>
          <list-item>
            <p>Toxoplasmosis</p>
          </list-item>
          <list-item>
            <p>Extrapulmonary TB</p>
          </list-item>
          <list-item>
            <p>Organ-based infectious causes of FUO:
<list list-type="bullet"><list-item><p>Subacute bacterial endocarditis (SBE)</p></list-item><list-item><p>Chronic sinusitis/mastoiditis</p></list-item><list-item><p>Chronic prostatitis</p></list-item><list-item><p>Discitis</p></list-item><list-item><p>Vascular graft infections</p></list-item><list-item><p>Whipple disease</p></list-item><list-item><p>Multicentric Castleman disease (MCD)</p></list-item><list-item><p>Cholecystitis</p></list-item><list-item><p>Lymphogranuloma venereum (LGV)</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Tickborne infections:
<list list-type="bullet"><list-item><p>Babesiosis, Ehrlichiosis</p></list-item><list-item><p>Anaplasmosis</p></list-item><list-item><p>Tickborne relapsing fever (rodent-infested cabins)</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Regional infections:
<list list-type="bullet"><list-item><p>Histoplasmosis</p></list-item><list-item><p>Coccidioidomycosis</p></list-item><list-item><p>Leptospirosis</p></list-item><list-item><p>Visceral leishmaniasis</p></list-item><list-item><p>Rat-bite fever</p></list-item><list-item><p>Louse-borne relapsing fever</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>
<bold>Malignant and Neoplastic Causes of FUO</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Lymphoma</p>
          </list-item>
          <list-item>
            <p>Renal cell carcinoma</p>
          </list-item>
          <list-item>
            <p>Myeloproliferative disorder</p>
          </list-item>
          <list-item>
            <p>Acute myelogenous leukemia</p>
          </list-item>
          <list-item>
            <p>Multiple myeloma</p>
          </list-item>
          <list-item>
            <p>Breast/liver/pancreatic/colon cancer</p>
          </list-item>
          <list-item>
            <p>Atrial myxoma</p>
          </list-item>
          <list-item>
            <p>Metastases to brain/liver</p>
          </list-item>
          <list-item>
            <p>Malignant histiocytosis</p>
          </list-item>
        </list>
        <p>
<bold>Miscellaneous Causes of FUO</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Cirrhosis (due to portal endotoxins)</p>
          </list-item>
          <list-item>
            <p>Drug fever</p>
          </list-item>
          <list-item>
            <p>Thyroiditis</p>
          </list-item>
          <list-item>
            <p>Crohn disease</p>
          </list-item>
          <list-item>
            <p>Pulmonary emboli</p>
          </list-item>
          <list-item>
            <p>Hypothalamic syndrome</p>
          </list-item>
          <list-item>
            <p>Familial periodic fever syndromes</p>
          </list-item>
          <list-item>
            <p>Cyclic neutropenia</p>
          </list-item>
          <list-item>
            <p>Factitious fever</p>
          </list-item>
        </list>
        <p>
<bold>Common Causes of Fever in the Different Subclasses</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Classic FUO:&#x000a0;The frequency of each category varies by both time and location, although, endocarditis, complicated urinary tract infections, abscesses, and tuberculosis (TB) are consistently reported in patients with classic FUO. In patients over the age of 65, connective tissue diseases are determined to be the cause of fever more frequently.<xref ref-type="bibr" rid="article-21718.r7">[7]</xref>&#x000a0;Fever in travelers is more likely to be secondary to infections such as malaria, typhoid fever, and acute HIV.<xref ref-type="bibr" rid="article-21718.r8">[8]</xref></p>
          </list-item>
          <list-item>
            <p>Nosocomial FUO: Healthcare-associated fevers can be&#x000a0;due to drug fever, complications post-operatively, venous thromboembolic disease, malignancy, transfusion-related reactions, or <italic toggle="yes">Clostridium difficile</italic> infection.<xref ref-type="bibr" rid="article-21718.r7">[7]</xref> Risk factors such as surgical procedures, instrumentation, intravascular devices, immobilization, and medications can help determine the diagnostic testing necessary to obtain a diagnosis.</p>
          </list-item>
          <list-item>
            <p>Neutropenic FUO: Fevers are common in this subclass and are frequently due to infection.</p>
          </list-item>
          <list-item>
            <p>HIV-related FUO: Fevers can be present during acute illness, but are also common in the setting of untreated infection signifying additional infection with opportunistic organisms.<xref ref-type="bibr" rid="article-21718.r9">[9]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-21718.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Epidemiology of fever of unknown origin (FUO) varies based on&#x000a0;etiology of fever, age group, geography, environmental exposure, and immune/HIV status. In developing countries, an infectious etiology of FUO is most prevalent whereas, in developed countries, FUO is likely due to non-infectious inflammatory disease.<xref ref-type="bibr" rid="article-21718.r6">[6]</xref></p>
      </sec>
      <sec id="article-21718.s5" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>There is no clear-cut diagnostic approach to fever of unknown origin (FUO). Thorough history with a focus on the most probable etiology based on the patient&#x02019;s symptoms is the key to pinpoint the origin of FUO. Information about previous illnesses, localizing symptoms, alcohol intake, home medications, occupational exposures, pets, travel, and familial disorders should not be overlooked. Constellation of patient-reported symptoms should help providers narrow down the etiology of the etiologic category of fevers as each of these has clinical hallmarks. For example, if a patient presents with B-symptoms, early satiety, and significant weight loss, the provider should pursue a malignancy workup. On the other hand, if a patient presents with rigors, an infectious&#x000a0;etiology should be considered, while joint involvement is a hallmark of rheumatologic disorders.<xref ref-type="bibr" rid="article-21718.r4">[4]</xref></p>
        <p>
<bold>Important Aspects of History</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Family history</p>
          </list-item>
          <list-item>
            <p>Immunization history</p>
          </list-item>
          <list-item>
            <p>Dental history</p>
          </list-item>
          <list-item>
            <p>Occupational history</p>
          </list-item>
          <list-item>
            <p>Travel history</p>
          </list-item>
          <list-item>
            <p>Nutrition and weight history</p>
          </list-item>
          <list-item>
            <p>Drug history (over-the-counter medications, illicit substances)</p>
          </list-item>
          <list-item>
            <p>Sexual history</p>
          </list-item>
          <list-item>
            <p>Recreational habits</p>
          </list-item>
          <list-item>
            <p>Animal contacts</p>
          </list-item>
          <list-item>
            <p>Surgery, trauma, or procedures</p>
          </list-item>
        </list>
        <p>
<bold>Fever Patterns</bold>
</p>
        <p>Importantly, fevers should be verified in a clinical setting, and fever patterns should be analyzed.&#x000a0;Fever pattern analysis can provide additional clues to specific infectious culprits.</p>
        <list list-type="bullet">
          <list-item>
            <p>Tertian or quartan fever in prolonged malaria (occurring every third or fourth day)</p>
          </list-item>
          <list-item>
            <p>Undulant fever in brucellosis (fevers and sweats in the evening, resolving by morning)</p>
          </list-item>
          <list-item>
            <p>Tick-borne relapsing fever in borreliosis (week-long fevers with week-long remissions)</p>
          </list-item>
          <list-item>
            <p>Pel-Ebstein fever in Hodgkin disease (week-long high fevers with week-long remissions)</p>
          </list-item>
          <list-item>
            <p>Periodic fevers in cyclic neutropenia</p>
          </list-item>
          <list-item>
            <p>Double quotidian fever (two fever spikes a day) in adult Still disease, malaria, and typhoid</p>
          </list-item>
        </list>
        <p>
<bold>Historical Clues and Physical Examination in Infectious Causes of FUO</bold>
</p>
        <p>If an infectious etiology is likely, history of presenting illness should include prior invasive procedures/surgeries, dentition,&#x000a0;TB exposure, pet contacts, mosquito/tick bites, rodent exposure, history of blood transfusions, and immunosuppressive drugs.</p>
        <list list-type="bullet">
          <list-item>
            <p>In case of an intraabdominal abscess, perinephric abscess, psoas abscess there would be a previous history of abdominal surgery, trauma, or a history of peritonitis,&#x000a0;endoscopy, urologic or gynecologic procedures.</p>
          </list-item>
          <list-item>
            <p>A history of exposure to unpasteurized dairy may suggest brucellosis, <italic toggle="yes">Q fever</italic>,&#x000a0;<italic toggle="yes">Yersinia enterocolitica.</italic></p>
          </list-item>
          <list-item>
            <p>Exposure to birds may suggest&#x000a0;<italic toggle="yes">Chlamydia psittaci</italic>&#x000a0;infection.</p>
          </list-item>
          <list-item>
            <p>Exposure to cats may suggest toxoplasmosis or cat scratch disease.</p>
          </list-item>
          <list-item>
            <p>Consider HIV, disseminated gonorrhea in travelers, and sexual encounters without barrier precautions.</p>
          </list-item>
          <list-item>
            <p>Acute Epstein-Barr virus (EBV) infection in day care centers as it spreads easily.</p>
          </list-item>
        </list>
        <p>Important physical exam findings include a new heart murmur which could be suggestive of bacterial endocarditis, spinal tenderness indicating vertebral osteomyelitis, splenomegaly concerning for miliary TB, epstein-barr virus (EBV), and cytomegalovirus (CMV) and epididymal nodule concerning for extrapulmonary TB.<xref ref-type="bibr" rid="article-21718.r4">[4]</xref></p>
        <p>
<bold>Historical Clues and Physical Examination in Malignant Causes of FUO</bold>
</p>
        <p>When considering malignancy, it is important to inquire about unintentional weight loss, age-appropriate cancer screening, family history of cancer, smoking, and alcohol use. On physical exam, one could notice relative bradycardia suggestive of lymphoma/ central nervous system (CNS) malignancy, a new heart murmur pointing toward atrial myxoma, or sternal tenderness which could be concerning for a myeloproliferative disorder. Isolated hepatomegaly and FUO could be indicative of a hepatoma or liver metastases.<xref ref-type="bibr" rid="article-21718.r4">[4]</xref></p>
        <p>
<bold>Historical Clues and Physical Examination in non Infectious Causes of FUO</bold>
</p>
        <p>Collagen vascular and autoimmune diseases can manifest as FUO if the fever precedes other, more specific manifestations such as arthritis, pneumonitis, or renal involvement. When considering rheumatologic disorder and FUO, ask about muscle and joint pain/stiffness, oral ulcers, and family history of autoimmune conditions. Rheumatologic etiology of FUO is less likely if a patient reports symptoms of rigors or chills. Fever distribution analysis could differentiate periarteritis nodosa (morning fevers) vs. adult Still disease (double quotidian). On physical exam, it is important to look for oral ulcers (Behcet disease, systemic lupus erythematosus [SLE]), unequal pulses (Takayasu arteritis), lymphadenopathy (SLE, RA, sarcoidosis), and rashes (sarcoidosis, SLE, adult Still disease). An epididymal nodule is a clue for periarteritis nodosa, SLE, and sarcoidosis whereas hepatomegaly without splenomegaly argues against rheumatologic disorders.<xref ref-type="bibr" rid="article-21718.r4">[4]</xref></p>
        <p>
<bold>Historical Clues and Physical Examination in Miscellaneous Causes of FUO</bold>
</p>
        <p>Cirrhosis and Crohn disease are often overlooked as miscellaneous causes of FUO. If suspected, it is important to inquire about past medical history, history of alcohol intake, intravenous drug use, non-alcoholic hepatosteatosis (NASH), and hepatitis. On physical examination, splenomegaly is an important diagnostic clue for Crohn disease and liver cirrhosis.<xref ref-type="bibr" rid="article-21718.r4">[4]</xref></p>
      </sec>
      <sec id="article-21718.s6" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>When working up the differential diagnosis for FUO, it is important to remember that the cause is more likely a subtle or&#x000a0;atypical manifestation of a common disease rather than a rare disease. Diagnosing a cause of FUO can be a cumbersome task and requires repeated diligent and thorough history taking along with a complete physical examination.</p>
        <p>
<bold>Non-invasive Tests</bold>
</p>
        <p>Initial diagnostic testing should include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Complete blood count with differential</p>
          </list-item>
          <list-item>
            <p>Complete metabolic panel&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Urine analysis with microscopy and urine culture</p>
          </list-item>
          <list-item>
            <p>Three sets of blood cultures (from different sites, several hours apart, and prior to initiation of antibiotic therapy)</p>
          </list-item>
          <list-item>
            <p>Chest radiograph</p>
          </list-item>
          <list-item>
            <p>Erythrocyte sedimentation rate (ESR)</p>
          </list-item>
          <list-item>
            <p>C-reactive protein (CRP)</p>
          </list-item>
          <list-item>
            <p>Lactate dehydrogenase (LDH)</p>
          </list-item>
          <list-item>
            <p>Creatinine phosphokinase</p>
          </list-item>
          <list-item>
            <p>ANA</p>
          </list-item>
          <list-item>
            <p>Rheumatoid factor</p>
          </list-item>
          <list-item>
            <p>Cytomegalovirus IgM/PCR</p>
          </list-item>
          <list-item>
            <p>Heterophile antibody test</p>
          </list-item>
          <list-item>
            <p>Tuberculin skin test or interferon-gamma release assay</p>
          </list-item>
          <list-item>
            <p>HIV immunoassay</p>
          </list-item>
          <list-item>
            <p>CT scan of the abdomen</p>
          </list-item>
          <list-item>
            <p>CT scan of the chest</p>
          </list-item>
          <list-item>
            <p>Cardiac echocardiography can be helpful if culture-negative endocarditis or atrial myxoma is suspected.</p>
          </list-item>
        </list>
        <p>To diagnose FUO, the non-invasive testing outlined above should have been inconclusive. At this point, a clinician should exclude surreptitious manipulation&#x000a0;of the thermometer and analyze patients' medication lists to evaluate for drug-induced fevers.<xref ref-type="bibr" rid="article-21718.r6">[6]</xref></p>
        <p>
<bold>Nuclear Medicine Tests</bold>
</p>
        <p>In the past, nuclear medicine testing was&#x000a0;generally&#x000a0;reserved for cases that remain undiagnosed after thorough initial evaluation. Recent European studies suggest utilizing fluorodeoxyglucose positron emission tomography (FDG-PET)/CT scan earlier in FUO workup, if available.<xref ref-type="bibr" rid="article-21718.r10">[10]</xref><xref ref-type="bibr" rid="article-21718.r11">[11]</xref><xref ref-type="bibr" rid="article-21718.r12">[12]</xref>&#x000a0;FDG-PET/CT and FDG/PET are highly sensitive and non-invasive diagnostic techniques for anatomic localization of infectious, inflammatory, or neoplastic processes and, although nonspecific, can guide further definitive tests such as biopsy or aspiration.</p>
        <p>If FDG-PET is not available, labeled leukocyte studies could be used as&#x000a0;an alternative; however, they might have a lower diagnostic yield. Gallium- and indium-labeled leukocyte studies are highly sensitive but not specific enough for establishing a diagnosis. However, these tests are helpful to localize the involved site for a targeted evaluation with a CT scan. Note that indium scans have a high rate of false negatives with bone infections. Positron emission tomography can aid in detecting obscure infections or malignancies.</p>
        <p>
<bold>Invasive Tests</bold>
</p>
        <p>The most common invasive tests associated with FUO are biopsies of lymph nodes, liver,&#x000a0; bone marrow, epididymal nodule, and temporal artery. These tests are performed only if the clinical picture or initial tests reveal findings that require histopathological evaluation. Biopsies are most commonly used to diagnose malignancy, certain infections, myeloproliferative disorders, and inflammatory conditions causing FUO. For example, temporal artery biopsy should be considered in a patient older than 60 years old and with significantly&#x000a0;elevated ESR, particularly, if there are other symptoms suggestive of giant cell arteritis. Additionally, if the physical examination reveals lymphadenopathy in a patient with FUO, lymph node biopsy is recommended and may reveal definitive etiology of fever.</p>
        <p>Endoscopic examination of the upper and lower gastrointestinal tract should be done, including retrograde cholangiography when indicated as for Crohn disease,&#x000a0;biliary tract disease, and gastrointestinal tumors. Crohn disease is the most common gastrointestinal cause of FUO. Diarrhea and other abdominal symptoms are sometimes absent in young adults.</p>
      </sec>
      <sec id="article-21718.s7" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>There is no single standard FUO management protocol given the variety of possible&#x000a0;etiologies. The most important thing is to investigate and rule out all possible&#x000a0;diagnoses. Specific treatment should be started, once a diagnosis is made. Please note that empiric antibiotics are not indicated unless the patient with FUO is neutropenic. Antibiotics may delay the diagnosis of some occult infections. Empiric glucocorticoids are also not indicated unless there is strong clinical suspicion for a specific rheumatologic diagnosis. However, in patients whose condition is deteriorating empiric therapeutic trials of antibiotics, steroids, or antituberculous agents may be considered.<xref ref-type="bibr" rid="article-21718.r5">[5]</xref>&#x000a0;Other exceptions to start antibiotic or steroid treatment despite inconclusive are:</p>
        <list list-type="bullet">
          <list-item>
            <p>Culture-negative endocarditis</p>
          </list-item>
          <list-item>
            <p>Cryptic disseminated TB (or, occasionally, other granulomatous infections)</p>
          </list-item>
          <list-item>
            <p>Temporal arteritis with suspected vision loss</p>
          </list-item>
        </list>
        <p>Patients with FUO rarely need surgical treatment.</p>
        <p>
<bold>Specific Examples of Treatment</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>In patients with hepatic granulomas, 50% respond to corticosteroid treatment while the other 50% resolve spontaneously.</p>
          </list-item>
          <list-item>
            <p>Patients with giant cell arteritis are treated with high doses of steroids, and if the patient is very ill or has a significant ocular compromise, intravenous steroids should be administered.</p>
          </list-item>
          <list-item>
            <p>In polymyalgia rheumatica, the treatment&#x000a0;is steroid therapy.</p>
          </list-item>
          <list-item>
            <p>When drug fever is suspected, discontinue the implicated drug. The patient would be afebrile after two days of stopping the causative drug.</p>
          </list-item>
        </list>
        <p>The naproxen test can be performed to differentiate infectious and neoplastic etiologies of FUO. The test is conducted over 3 to 4 days, during which patient temperatures are trended while a patient is given naproxen. If temperatures decrease substantially, malignant/neoplastic etiology is likely. However, if temperatures remain the same or only minimally decrease, the FUO is likely of infectious origin. The utility of the naproxen&#x000a0;test is not well studied, and at this time,&#x000a0;experts believe the test is not specific enough to be useful for the individual patient.</p>
        <p>It is important to remember that up to 51% of cases remain undiagnosed. However, the prognosis for these patients is generally&#x000a0;good, and it is highly probable that FUO will spontaneously resolve in weeks to months. In stable patients without a diagnosis, non-steroidal anti-inflammatory drugs could be used for symptomatic management.<xref ref-type="bibr" rid="article-21718.r6">[6]</xref></p>
      </sec>
      <sec id="article-21718.s8" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis for FUO is&#x000a0;broad&#x000a0;but can be grouped into the following four categories based on etiology: infections, neoplasms, connective tissue disease, and miscellaneous.</p>
        <p>Infection accounts for about a third of cases of FUO. The most common infections causing FUO are:</p>
        <list list-type="bullet">
          <list-item>
            <p>Miliary tuberculosis (TB)</p>
          </list-item>
          <list-item>
            <p>Brucellosis</p>
          </list-item>
          <list-item>
            <p>Q fever</p>
          </list-item>
          <list-item>
            <p>Intraabdominal, pelvic, intranephric, and perinephric abscesses</p>
          </list-item>
          <list-item>
            <p>Typhoid/enteric fever</p>
          </list-item>
          <list-item>
            <p>Actinomycosis</p>
          </list-item>
          <list-item>
            <p>Amebiasis</p>
          </list-item>
          <list-item>
            <p>Atypical mycobacterial infection</p>
          </list-item>
          <list-item>
            <p>Blastomycosis</p>
          </list-item>
          <list-item>
            <p>Brain abscess</p>
          </list-item>
          <list-item>
            <p>Campylobacter infections</p>
          </list-item>
          <list-item>
            <p>Cholangitis</p>
          </list-item>
          <list-item>
            <p>Cholelithiasis</p>
          </list-item>
          <list-item>
            <p>Chagas disease</p>
          </list-item>
          <list-item>
            <p>Candidiasis</p>
          </list-item>
          <list-item>
            <p>Dengue fever</p>
          </list-item>
          <list-item>
            <p>Diabetic ulcers</p>
          </list-item>
          <list-item>
            <p>Empyema thoracis</p>
          </list-item>
          <list-item>
            <p>Empyema gallbladder</p>
          </list-item>
          <list-item>
            <p>Toxoplasmosis</p>
          </list-item>
          <list-item>
            <p>Giardiasis</p>
          </list-item>
          <list-item>
            <p>Hepatitis A-E</p>
          </list-item>
          <list-item>
            <p>Liver abscess</p>
          </list-item>
          <list-item>
            <p>Lung abscess</p>
          </list-item>
          <list-item>
            <p>Leptospirosis</p>
          </list-item>
          <list-item>
            <p>Leishmaniasis</p>
          </list-item>
          <list-item>
            <p>Libman-sacks endocarditis</p>
          </list-item>
          <list-item>
            <p>Cat scratch disease (CSD)</p>
          </list-item>
          <list-item>
            <p>Malaria</p>
          </list-item>
          <list-item>
            <p>Mycoplasma</p>
          </list-item>
          <list-item>
            <p>Mucormycosis</p>
          </list-item>
          <list-item>
            <p>SARS COVID 19</p>
          </list-item>
          <list-item>
            <p>Pelvic inflammatory disease</p>
          </list-item>
          <list-item>
            <p>HIV</p>
          </list-item>
          <list-item>
            <p>Cytomegalovirus</p>
          </list-item>
          <list-item>
            <p>Epstein-Barr virus</p>
          </list-item>
          <list-item>
            <p>Extrapulmonary (renal, central nervous system) TB</p>
          </list-item>
        </list>
        <p>Note that in the HIV population 75% of cases of FUO are infectious but rarely due to HIV itself.<xref ref-type="bibr" rid="article-21718.r4">[4]</xref></p>
        <p>Another third of FUO cases is due to rheumatologic and inflammatory disorders, such as:</p>
        <list list-type="bullet">
          <list-item>
            <p>Adult Still disease</p>
          </list-item>
          <list-item>
            <p>Giant cell/temporal arteritis</p>
          </list-item>
          <list-item>
            <p>Periarteritis nodosa</p>
          </list-item>
          <list-item>
            <p>Microscopic polyangiitis</p>
          </list-item>
          <list-item>
            <p>Rheumatoid arthritis (RA)</p>
          </list-item>
          <list-item>
            <p>Systemic lupus erythematosus (SLE)</p>
          </list-item>
          <list-item>
            <p>Takayasu arteritis</p>
          </list-item>
          <list-item>
            <p>Kikuchi disease</p>
          </list-item>
          <list-item>
            <p>Sarcoidosis</p>
          </list-item>
          <list-item>
            <p>Felty syndrome</p>
          </list-item>
          <list-item>
            <p>Gaucher disease</p>
          </list-item>
          <list-item>
            <p>Polyarticular gout</p>
          </list-item>
          <list-item>
            <p>Pseudogout</p>
          </list-item>
          <list-item>
            <p>Antiphospholipid syndrome (APS)</p>
          </list-item>
          <list-item>
            <p>Behcet disease</p>
          </list-item>
          <list-item>
            <p>Marshall syndrome<xref ref-type="bibr" rid="article-21718.r4">[4]</xref></p>
          </list-item>
        </list>
        <p>Neoplasms and malignancies account for up to 18% of FUO etiologies. The most common neoplasms associated with FUO are:</p>
        <list list-type="bullet">
          <list-item>
            <p>Lymphoma</p>
          </list-item>
          <list-item>
            <p>Renal cell carcinoma</p>
          </list-item>
          <list-item>
            <p>Acute myeloid leukemia</p>
          </list-item>
          <list-item>
            <p>Myeloproliferative disorders</p>
          </list-item>
          <list-item>
            <p>Atrial myxoma</p>
          </list-item>
          <list-item>
            <p>Multiple myeloma</p>
          </list-item>
          <list-item>
            <p>Colon carcinoma</p>
          </list-item>
          <list-item>
            <p>Pancreatic carcinoma</p>
          </list-item>
          <list-item>
            <p>Hepatoma</p>
          </list-item>
          <list-item>
            <p>CNC metastasis</p>
          </list-item>
          <list-item>
            <p>Liver metastasis</p>
          </list-item>
          <list-item>
            <p>Systemic mastocytosis<xref ref-type="bibr" rid="article-21718.r4">[4]</xref></p>
          </list-item>
        </list>
        <p>The remainder of FUO etiologies is classified as miscellaneous. These include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Drug-induced fevers</p>
          </list-item>
          <list-item>
            <p>Liver cirrhosis</p>
          </list-item>
          <list-item>
            <p>Subacute thyroiditis</p>
          </list-item>
          <list-item>
            <p>Crohn disease</p>
          </list-item>
          <list-item>
            <p>Deep vein thrombosis</p>
          </list-item>
          <list-item>
            <p>Pulmonary embolus</p>
          </list-item>
          <list-item>
            <p>Hematomas</p>
          </list-item>
          <list-item>
            <p>Familial Mediterranean fever</p>
          </list-item>
          <list-item>
            <p>Hypothalamic dysfunction</p>
          </list-item>
          <list-item>
            <p>Hypertriglyceridemia (type V)</p>
          </list-item>
          <list-item>
            <p>Fictitious fever<xref ref-type="bibr" rid="article-21718.r4">[4]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-21718.s9" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of fever of unknown origin (FUO) varies based on the etiology of the fever and by the nature of the underlying disease. However poorer prognosis has been reported in elderly patients and those diagnosed with a malignancy.&#x000a0;Children without a discernible cause, eventually, do better than adults.&#x000a0;</p>
      </sec>
      <sec id="article-21718.s10" sec-type="Complications">
        <title>Complications</title>
        <p>Complications also vary based on the diagnosis of certain diseases that may have been causing fever of unknown origin (FUO).&#x000a0;Interestingly, patients with an undiagnosed cause of FUO have favorable outcomes and no reported complications after fever resolution.<xref ref-type="bibr" rid="article-21718.r13">[13]</xref></p>
      </sec>
      <sec id="article-21718.s11" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>It is important for patients to note the difficulties associated with the diagnostic process when one presents with a fever of unknown origin. Patients should work together with providers by providing a thorough history to aid in directed diagnostic testing.</p>
      </sec>
      <sec id="article-21718.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>In modern medicine, FUO&#x000a0;remains one of the most challenging diagnoses as it can be caused by over 200 neoplastic, infectious, inflammatory, and miscellaneous disorders. Diagnosing FUO requires a thorough history, repeated physical examinations, and selective&#x000a0;diagnostic testing. Providers&#x000a0;should avoid taking a &#x0201c;shot-gun&#x0201d; approach early in the FUO workup as it can be misleading. Directed diagnostic testing based on a patient's history and physical is more likely to yield a diagnosis and is more cost-effective.</p>
        <p>An interdisciplinary approach is important while pursuing work-up for FUO. It is important to communicate the importance of monitoring fevers without treatment when appropriate&#x000a0;with nursing staff to evaluate fever curves and guide additional testing. Primary care providers and hospitalists should&#x000a0;work together with specialists (based on etiology, but could include infectious diseases, rheumatology, or hematology/oncology) to ensure early diagnosis and treatment. Discussing the case with the pharmacy can also be beneficial in determining whether any medications the patient is taking can be causing drug-induced fevers.</p>
      </sec>
      <sec id="article-21718.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21718&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21718">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/health/fever-of-unknown-origin/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=21718">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/21718/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=21718">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-21718.s14">
        <title>References</title>
        <ref id="article-21718.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>PETERSDORF</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>BEESON</surname>
                <given-names>PB</given-names>
              </name>
            </person-group>
            <article-title>Fever of unexplained origin: report on 100 cases.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>1961</year>
            <month>Feb</month>
            <volume>40</volume>
            <fpage>1</fpage>
            <page-range>1-30</page-range>
            <pub-id pub-id-type="pmid">13734791</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21718.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Durack</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Street</surname>
                <given-names>AC</given-names>
              </name>
            </person-group>
            <article-title>Fever of unknown origin--reexamined and redefined.</article-title>
            <source>Curr Clin Top Infect Dis</source>
            <year>1991</year>
            <volume>11</volume>
            <fpage>35</fpage>
            <page-range>35-51</page-range>
            <pub-id pub-id-type="pmid">1651090</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21718.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arnow</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Flaherty</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Fever of unknown origin.</article-title>
            <source>Lancet</source>
            <year>1997</year>
            <month>Aug</month>
            <day>23</day>
            <volume>350</volume>
            <issue>9077</issue>
            <fpage>575</fpage>
            <page-range>575-80</page-range>
            <pub-id pub-id-type="pmid">9284789</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21718.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cunha</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Lortholary</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Cunha</surname>
                <given-names>CB</given-names>
              </name>
            </person-group>
            <article-title>Fever of unknown origin: a clinical approach.</article-title>
            <source>Am J Med</source>
            <year>2015</year>
            <month>Oct</month>
            <volume>128</volume>
            <issue>10</issue>
            <fpage>1138.e1</fpage>
            <page-range>1138.e1-1138.e15</page-range>
            <pub-id pub-id-type="pmid">26093175</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21718.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bleeker-Rovers</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Vos</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>de Kleijn</surname>
                <given-names>EMHA</given-names>
              </name>
              <name>
                <surname>Mudde</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Dofferhoff</surname>
                <given-names>TSM</given-names>
              </name>
              <name>
                <surname>Richter</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Smilde</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Krabbe</surname>
                <given-names>PFM</given-names>
              </name>
              <name>
                <surname>Oyen</surname>
                <given-names>WJG</given-names>
              </name>
              <name>
                <surname>van der Meer</surname>
                <given-names>JWM</given-names>
              </name>
            </person-group>
            <article-title>A prospective multicenter study on fever of unknown origin: the yield of a structured diagnostic protocol.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2007</year>
            <month>Jan</month>
            <volume>86</volume>
            <issue>1</issue>
            <fpage>26</fpage>
            <page-range>26-38</page-range>
            <pub-id pub-id-type="pmid">17220753</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21718.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mulders-Manders</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Simon</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bleeker-Rovers</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Fever of unknown origin.</article-title>
            <source>Clin Med (Lond)</source>
            <year>2015</year>
            <month>Jun</month>
            <volume>15</volume>
            <issue>3</issue>
            <fpage>280</fpage>
            <page-range>280-4</page-range>
            <pub-id pub-id-type="pmid">26031980</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21718.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hayakawa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ramasamy</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Chandrasekar</surname>
                <given-names>PH</given-names>
              </name>
            </person-group>
            <article-title>Fever of unknown origin: an evidence-based review.</article-title>
            <source>Am J Med Sci</source>
            <year>2012</year>
            <month>Oct</month>
            <volume>344</volume>
            <issue>4</issue>
            <fpage>307</fpage>
            <page-range>307-16</page-range>
            <pub-id pub-id-type="pmid">22475734</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21718.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Speil</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mushtaq</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Adamski</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Khardori</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Fever of unknown origin in the returning traveler.</article-title>
            <source>Infect Dis Clin North Am</source>
            <year>2007</year>
            <month>Dec</month>
            <volume>21</volume>
            <issue>4</issue>
            <fpage>1091</fpage>
            <page-range>1091-113, x</page-range>
            <pub-id pub-id-type="pmid">18061090</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21718.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sepkowitz</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <article-title>Effect of prophylaxis on the clinical manifestations of AIDS-related opportunistic infections.</article-title>
            <source>Clin Infect Dis</source>
            <year>1998</year>
            <month>Apr</month>
            <volume>26</volume>
            <issue>4</issue>
            <fpage>806</fpage>
            <page-range>806-10</page-range>
            <pub-id pub-id-type="pmid">9564456</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21718.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bleeker-Rovers</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Vos</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Corstens</surname>
                <given-names>FH</given-names>
              </name>
              <name>
                <surname>Oyen</surname>
                <given-names>WJ</given-names>
              </name>
            </person-group>
            <article-title>Imaging of infectious diseases using [18F] fluorodeoxyglucose PET.</article-title>
            <source>Q J Nucl Med Mol Imaging</source>
            <year>2008</year>
            <month>Mar</month>
            <volume>52</volume>
            <issue>1</issue>
            <fpage>17</fpage>
            <page-range>17-29</page-range>
            <pub-id pub-id-type="pmid">17657204</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21718.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sch&#x000f6;nau</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Vogel</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Englbrecht</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wacker</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Manger</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kuwert</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Schett</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>The value of <sup>18</sup>F-FDG-PET/CT in identifying the cause of fever of unknown origin (FUO) and inflammation of unknown origin (IUO): data from a prospective study.</article-title>
            <source>Ann Rheum Dis</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>77</volume>
            <issue>1</issue>
            <fpage>70</fpage>
            <page-range>70-77</page-range>
            <pub-id pub-id-type="pmid">28928271</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21718.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kouijzer</surname>
                <given-names>IJE</given-names>
              </name>
              <name>
                <surname>Mulders-Manders</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Bleeker-Rovers</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Oyen</surname>
                <given-names>WJG</given-names>
              </name>
            </person-group>
            <article-title>Fever of Unknown Origin: the Value of FDG-PET/CT.</article-title>
            <source>Semin Nucl Med</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>48</volume>
            <issue>2</issue>
            <fpage>100</fpage>
            <page-range>100-107</page-range>
            <pub-id pub-id-type="pmid">29452615</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21718.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mansueto</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Di Lorenzo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Rizzo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Di Rosa</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Vitale</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Rini</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mansueto</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Affronti</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Fever of unknown origin in a Mediterranean survey from a division of internal medicine: report of 91 cases during a 12-year-period (1991-2002).</article-title>
            <source>Intern Emerg Med</source>
            <year>2008</year>
            <month>Sep</month>
            <volume>3</volume>
            <issue>3</issue>
            <fpage>219</fpage>
            <page-range>219-25</page-range>
            <pub-id pub-id-type="pmid">18264668</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
